Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Chiodo

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Le Infezioni in Medicina|April 19, 2003
[Effects induced by the introduction of highly active antiretroviral therapy (HAART) on disseminated bacterial infection during HIV disease]Roberto Manfredi, Francesco Chiodo
Clinical Drug Investigation|May 30, 2007
Long-Term 'Self-Managed' Immunosuppressive Treatment Resulting in Death due to Fulminant Hepatitis B : Medical Malpractice or Patient's Autolesionism?Roberto Manfredi, Sergio Sabbatani, Francesco Chiodo
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2005
An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: efavirenz and nevirapineRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Le Infezioni in Medicina|February 25, 2005
Immigration, HIV infection, and antiretroviral therapy in Italy. An epidemiological and clinical surveyRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|June 19, 2004
[Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)]Leonardo Calza, Roberto Manfredi, Francesco Chiodo
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Polyunsaturated ethyl esters of n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapyRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2004
Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational studyRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Clinical Nutrition (Edinburgh, Scotland)|February 1, 2005
Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapyLeonardo Calza, Roberto Manfredi, Francesco Chiodo
AIDS (London, England)|January 28, 2006
Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAARTRoberto Manfredi, Leonardo Calza, Francesco Chiodo
International Journal of Antimicrobial Agents|August 21, 2003
Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and managementLeonardo Calza, Roberto Manfredi, Francesco Chiodo
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Le Infezioni in Medicina|April 19, 2003
[Effects induced by the introduction of highly active antiretroviral therapy (HAART) on disseminated bacterial infection during HIV disease]Roberto Manfredi, Francesco Chiodo
Clinical Drug Investigation|May 30, 2007
Long-Term 'Self-Managed' Immunosuppressive Treatment Resulting in Death due to Fulminant Hepatitis B : Medical Malpractice or Patient's Autolesionism?Roberto Manfredi, Sergio Sabbatani, Francesco Chiodo
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2005
An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: efavirenz and nevirapineRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Le Infezioni in Medicina|February 25, 2005
Immigration, HIV infection, and antiretroviral therapy in Italy. An epidemiological and clinical surveyRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|June 19, 2004
[Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)]Leonardo Calza, Roberto Manfredi, Francesco Chiodo
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Polyunsaturated ethyl esters of n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapyRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2004
Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational studyRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Clinical Nutrition (Edinburgh, Scotland)|February 1, 2005
Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapyLeonardo Calza, Roberto Manfredi, Francesco Chiodo
AIDS (London, England)|January 28, 2006
Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAARTRoberto Manfredi, Leonardo Calza, Francesco Chiodo
International Journal of Antimicrobial Agents|August 21, 2003
Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and managementLeonardo Calza, Roberto Manfredi, Francesco Chiodo
Pageof 11